Fatty liver fight: soy extract vs. betaine in Head-to-Head trial
NCT ID NCT07194863
Summary
This study aims to see which of two dietary supplements works better to reduce fat in the liver for people with metabolic-associated fatty liver disease (MAFLD). It will involve 200 adults diagnosed with fatty liver. Researchers will measure changes in liver fat using medical imaging to compare the effectiveness of essential phospholipids (from soybeans) against betaine HCL/L-glutamic acid.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL PHOSPHOLIPID IN METABOLIC ASSOCIATED FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.